With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.
CoreMedic announced that it picked up new funding in a Series B extension to support its transcatheter mitral valve repair ...
Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ...
Open heart surgery for aortic or mitral valve repair or replacement has traditionally required opening the patient’s chest through their sternum (breast bone). In many cases today, a minimally ...
The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...
With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.
Beyond surgical excellence, St. Elizabeth prioritizes a highly specialized and patient-focused approach to cardiac care.
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback